MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma
Preoperative Evaluation of Resectability in Gastroesophageal Junction and Upper Gastric Adenocarcinoma Utilizing Multi-Parametric MRI and CT Imaging.
1 other identifier
observational
100
1 country
1
Brief Summary
Accurate preoperative Siewert classification, precise assessment of the extent of esophageal involvement, and staging is crucial for determining the appropriate surgical approach and achieving negative resection margins. The purpose of this study is to investigate the diagnostic performance of the Multi-parametric magnetic resonance imaging (mpMRI) and computed tomography (CT) in gastroesophageal junction and upper gastric cancers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 21, 2024
CompletedFirst Submitted
Initial submission to the registry
October 7, 2024
CompletedFirst Posted
Study publicly available on registry
October 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 24, 2027
ExpectedOctober 15, 2024
October 1, 2024
1 year
October 7, 2024
October 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Siewert classification
Compare the findings of multiparametric MRI and CT in the Siewert classification (Types I, II, and III) against a histopathological reference standard, evaluating sensitivity, specificity, positive predictive value, and negative predictive value.
2 years
length of esophageal involvement
The accuracy and AUC of length of esophageal involvement (not involved, 0-2cm, 2-3cm, 3-4cm, \>4cm) evaluated by CT and MRI.
2 years
Staging
Compare the cancer stage (according to AJCC 8th edition TNM-classification) as determined by mpMRI compared to CT at primary staging and at restaging. The proportion of upgraded, downgraded, and right patients are determined.
2 years
Secondary Outcomes (2)
Survival time and recurrence time
3 years
The number of patients with complications
Within 30 days after the day of operation
Study Arms (1)
Experimental: Gastroesophageal junction or upper gastric adenocarcinoma
Patients with biopsy verified gastroesophageal junction or upper gastric adenocarcinoma undergo mpMRI in addition to conventional CT imaging
Interventions
Gastroesophageal junction or upper gastric adenocarcinoma patients undergo mpMRI at siewert classification, length of esophageal involvement, primary staging and restaging
Eligibility Criteria
Patients diagnosed with gastroesophageal junction or upper gastric adenocarcinoma who are candidates for radical surgical intervention.
You may qualify if:
- patients with gastric cancer confirmed by preoperative gastroscopic biopsy;
- underwent standardized mpMRI and CT examination;
- patients with complete postoperative pathological data and pathological results of gastroesophageal Junction or upper gastric adenocarcinoma;
You may not qualify if:
- combined with other tumors;
- Clinical and imaging data were missing or could not meet the research needs;
- the location of lesions could not be determined;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2024
First Posted
October 15, 2024
Study Start
August 21, 2024
Primary Completion
August 24, 2025
Study Completion (Estimated)
August 24, 2027
Last Updated
October 15, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share